We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQAL icon
1226
Invesco Russell 1000 Equal Weight ETF
EQAL
$822M
$205K ﹤0.01%
4,209
JJSF icon
1227
J&J Snack Foods
JJSF
$1.49B
$204K ﹤0.01%
+1,187
New +$199K
PJT icon
1228
PJT Partners
PJT
$4.47B
$203K ﹤0.01%
1,526
-342
-18% -$41.8K
KFY icon
1229
Korn Ferry
KFY
$4.26B
$203K ﹤0.01%
+2,695
New +$189K
CSGS
1230
DELISTED
CSG Systems International
CSGS
$202K ﹤0.01%
+4,161
New +$190K
MGC icon
1231
Vanguard Mega Cap 300 Index ETF
MGC
$9.88B
$202K ﹤0.01%
979
ARRY icon
1232
Array Technologies
ARRY
$785M
$200K ﹤0.01%
30,310
+88
+0.3% +$723
CDMO
1233
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$199K ﹤0.01%
17,498
+4,812
+38% +$48.3K
BF.A icon
1234
Brown-Forman Class A
BF.A
$13.4B
$198K ﹤0.01%
4,117
+78
+2% +$3.52K
TFSL icon
1235
TFS Financial
TFSL
$5.18B
$195K ﹤0.01%
15,156
+156
+1% +$2.06K
HEDJ icon
1236
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.83B
$194K ﹤0.01%
4,316
-890
-17% -$39.3K
ZION icon
1237
Zions Bancorporation
ZION
$10.1B
$194K ﹤0.01%
4,099
-1,095
-21% -$51.8K
SPHD icon
1238
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.42B
$191K ﹤0.01%
3,781
PBR icon
1239
Petrobras
PBR
$116B
$189K ﹤0.01%
13,084
-1,600
-11% -$23.5K
AUR icon
1240
Aurora
AUR
$12.2B
$188K ﹤0.01%
31,779
+4,054
+15% +$16.9K
PTH icon
1241
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$220M
$188K ﹤0.01%
4,041
VOD icon
1242
Vodafone
VOD
$37.7B
$186K ﹤0.01%
18,586
-5,365
-22% -$51.2K
NWG icon
1243
NatWest
NWG
$70.6B
$186K ﹤0.01%
19,880
+738
+4% +$6.57K
BLOK icon
1244
Amplify Blockchain Technology ETF
BLOK
$1.08B
$186K ﹤0.01%
4,950
AHCO icon
1245
AdaptHealth
AHCO
$1.53B
$185K ﹤0.01%
16,453
+4,556
+38% +$48.4K
PPA icon
1246
Invesco Aerospace & Defense ETF
PPA
$8.39B
$175K ﹤0.01%
1,523
SCHG icon
1247
Schwab US Large-Cap Growth ETF
SCHG
$59.1B
$171K ﹤0.01%
6,580
XMMO icon
1248
Invesco S&P MidCap Momentum ETF
XMMO
$7.15B
$171K ﹤0.01%
1,420
HCSG icon
1249
Healthcare Services Group
HCSG
$1.63B
$170K ﹤0.01%
+15,253
New +$167K
LUMN icon
1250
Lumen
LUMN
$6.38B
$170K ﹤0.01%
23,961
+8,152
+52% +$34.8K

Similar funds

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.